{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:42:21Z","timestamp":1789990941883,"version":"4.0.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,11,30]],"date-time":"2012-11-30T00:00:00Z","timestamp":1354233600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s10875-012-9834-5","type":"journal-article","created":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T11:56:24Z","timestamp":1354190184000},"page":"567-576","source":"Crossref","is-referenced-by-count":72,"title":["MiR-320a is Downregulated in Patients with Myasthenia Gravis and Modulates Inflammatory Cytokines Production by Targeting Mitogen-activated Protein Kinase 1"],"prefix":"10.1007","volume":"33","author":[{"given":"Zhuoan","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaobo","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anle","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,11,30]]},"reference":[{"key":"9834_CR1","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jaut.2011.05.006","volume":"37","author":"E Tuzun","year":"2011","unstructured":"Tuzun E, Huda R, Christadoss P. Complement and cytokine based therapeutic strategies in myasthenia gravis. J Autoimmun. 2011;37:136\u201343.","journal-title":"J Autoimmun"},{"key":"9834_CR2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00011-009-0087-6","volume":"59","author":"H Yang","year":"2010","unstructured":"Yang H, Zhang Y, Wu M, Li J, Zhou W, Li G, et al. Suppression of ongoing experimental autoimmune myasthenia gravis by transfer of RelB-silenced bone marrow dentritic cells is associated with a change from a T helper Th17\/Th1 to a Th2 and FoxP3+ regulatory T-cell profile. Inflamm Res. 2010;59:197\u2013205.","journal-title":"Inflamm Res"},{"key":"9834_CR3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2249.2007.03356.x","volume":"148","author":"B Afzali","year":"2007","unstructured":"Afzali B, Lombardi G, Lechler RI, Lord GM. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol. 2007;148:32\u201346.","journal-title":"Clin Exp Immunol"},{"key":"9834_CR4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215\u201333.","journal-title":"Cell"},{"key":"9834_CR5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jaut.2009.02.012","volume":"32","author":"KM Pauley","year":"2009","unstructured":"Pauley KM, Cha S, Chan EK. MicroRNA in autoimmunity and autoimmune diseases. J Autoimmun. 2009;32:189\u201394.","journal-title":"J Autoimmun"},{"key":"9834_CR6","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/art.23429","volume":"58","author":"T Nakasa","year":"2008","unstructured":"Nakasa T, Miyaki S, Okubo A, Hashimoto M, Nishida K, Ochi M, et al. Expression of microRNA-146 in rheumatoid arthritis synovial tissue. Arthritis Rheum. 2008;58:1284\u201392.","journal-title":"Arthritis Rheum"},{"key":"9834_CR7","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.coph.2009.05.003","volume":"9","author":"E Tsitsiou","year":"2009","unstructured":"Tsitsiou E, Lindsay MA. microRNAs and the immune response. Curr Opin Pharmacol. 2009;9:514\u201320.","journal-title":"Curr Opin Pharmacol"},{"key":"9834_CR8","doi-asserted-by":"crossref","first-page":"6773","DOI":"10.4049\/jimmunol.0904060","volume":"184","author":"W Pan","year":"2010","unstructured":"Pan W, Zhu S, Yuan M, Cui H, Wang L, Luo X, et al. MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J Immunol. 2010;184:6773\u201381.","journal-title":"J Immunol"},{"key":"9834_CR9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.intimp.2012.07.003","volume":"14","author":"L Jiang","year":"2012","unstructured":"Jiang L, Cheng Z, Qiu S, Que Z, Bao W, Jiang C, et al. Altered let-7 expression in Myasthenia gravis and let-7c mediated regulation of IL-10 by directly targeting IL-10 in Jurkat cells. Int Immunopharmacol. 2012;14:217\u201323.","journal-title":"Int Immunopharmacol"},{"key":"9834_CR10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0165-5728(00)00285-X","volume":"108","author":"MQ Xia","year":"2000","unstructured":"Xia MQ, Bacskai BJ, Knowles RB, Qin SX, Hyman BT. Expression of the chemokine receptor CXCR3 on neurons and the elevated expression of its ligand IP-10 in reactive astrocytes: in vitro ERK1\/2 activation and role in Alzheimer\u2019s disease. J Neuroimmunol. 2000;108:227\u201335.","journal-title":"J Neuroimmunol"},{"key":"9834_CR11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1521-6616(02)00052-9","volume":"106","author":"S Cedeno","year":"2003","unstructured":"Cedeno S, Cifarelli DF, Blasini AM, Paris M, Placeres F, Alonso G, et al. Defective activity of ERK-1 and ERK-2 mitogen-activated protein kinases in peripheral blood T lymphocytes from patients with systemic lupus erythematosus: potential role of altered coupling of Ras guanine nucleotide exchange factor hSos to adapter protein Grb2 in lupus T cells. Clin Immunol. 2003;106:41\u20139.","journal-title":"Clin Immunol"},{"key":"9834_CR12","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.clim.2007.07.006","volume":"125","author":"MP Bernard","year":"2007","unstructured":"Bernard MP, Phipps RP. CpG oligodeoxynucleotides induce cyclooxygenase-2 in human B lymphocytes: implications for adjuvant activity and antibody production. Clin Immunol. 2007;125:138\u201348.","journal-title":"Clin Immunol"},{"key":"9834_CR13","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0009-9236(98)90042-X","volume":"63","author":"T Hirano","year":"1998","unstructured":"Hirano T, Oka K, Umezawa Y, Hirata M, Oh-i T, Koga M. Individual pharmacodynamics assessed by antilymphocyte action predicts clinical cyclosporine efficacy in psoriasis. Clin Pharmacol Ther. 1998;63:465\u201370.","journal-title":"Clin Pharmacol Ther"},{"key":"9834_CR14","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.cub.2005.06.037","volume":"15","author":"CA Dimitri","year":"2005","unstructured":"Dimitri CA, Dowdle W, MacKeigan JP, Blenis J, Murphy LO. Spatially separate docking sites on ERK2 regulate distinct signaling events in vivo. Curr Biol. 2005;15:1319\u201324.","journal-title":"Curr Biol"},{"key":"9834_CR15","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/(SICI)1097-4598(199705)20:5<543::AID-MUS2>3.0.CO;2-9","volume":"20","author":"GX Zhang","year":"1997","unstructured":"Zhang GX, Navikas V, Link H. Cytokines and the pathogenesis of myasthenia gravis. Muscle Nerve. 1997;20:543\u201351.","journal-title":"Muscle Nerve"},{"key":"9834_CR16","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1016\/j.molimm.2007.12.011","volume":"45","author":"LM Williams","year":"2008","unstructured":"Williams LM, Lali F, Willetts K, Balague C, Godessart N, Brennan F, et al. Rac mediates TNF-induced cytokine production via modulation of NF-kappaB. Mol Immunol. 2008;45:2446\u201354.","journal-title":"Mol Immunol"},{"key":"9834_CR17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jneuroim.2011.03.002","volume":"234","author":"H Qi","year":"2011","unstructured":"Qi H, Li J, Allman W, Saini SS, Tuzun E, Wu X, et al. Genetic deficiency of estrogen receptor alpha fails to influence experimental autoimmune myasthenia gravis pathogenesis. J Neuroimmunol. 2011;234:165\u20137.","journal-title":"J Neuroimmunol"},{"key":"9834_CR18","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jneuroim.2010.10.024","volume":"232","author":"K Vrolix","year":"2011","unstructured":"Vrolix K, Niks EH, Le Panse R, van Ostaijen-Ten Dam MM, Muris AH, der Zijde CM J-v, et al. Reduced thymic expression of ErbB receptors without auto-antibodies against synaptic ErbB in myasthenia gravis. J Neuroimmunol. 2011;232:158\u201365.","journal-title":"J Neuroimmunol"},{"key":"9834_CR19","doi-asserted-by":"crossref","first-page":"29223","DOI":"10.1074\/jbc.M110.144576","volume":"285","author":"S Sepramaniam","year":"2010","unstructured":"Sepramaniam S, Armugam A, Lim KY, Karolina DS, Swaminathan P, Tan JR, et al. MicroRNA 320a functions as a novel endogenous modulator of aquaporins 1 and 4 as well as a potential therapeutic target in cerebral ischemia. J Biol Chem. 2010;285:29223\u201330.","journal-title":"J Biol Chem"},{"key":"9834_CR20","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1182\/blood-2009-02-206706","volume":"116","author":"C Diakos","year":"2010","unstructured":"Diakos C, Zhong S, Xiao Y, Zhou M, Vasconcelos GM, Krapf G, et al. TEL-AML1 regulation of survivin and apoptosis via miRNA-494 and miRNA-320a. Blood. 2010;116:4885\u201393.","journal-title":"Blood"},{"key":"9834_CR21","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.bbrc.2012.03.075","volume":"420","author":"JY Sun","year":"2012","unstructured":"Sun JY, Huang Y, Li JP, Zhang X, Wang L, Meng YL, et al. MicroRNA-320a suppresses human colon cancer cell proliferation by directly targeting beta-catenin. Biochem Biophys Res Commun. 2012;420:787\u201392.","journal-title":"Biochem Biophys Res Commun"},{"key":"9834_CR22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.clim.2011.04.013","volume":"141","author":"L Mu","year":"2011","unstructured":"Mu L, Zhang Y, Sun B, Wang J, Xie X, Li N, et al. Activation of the receptor for advanced glycation end products (RAGE) exacerbates experimental autoimmune myasthenia gravis symptoms. Clin Immunol. 2011;141:36\u201348.","journal-title":"Clin Immunol"},{"key":"9834_CR23","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1006\/clim.2000.4850","volume":"95","author":"HB Wang","year":"2000","unstructured":"Wang HB, Shi FD, Li H, van der Meide PH, Ljunggren HG, Link H. Role for interferon-gamma in rat strains with different susceptibility to experimental autoimmune myasthenia gravis. Clin Immunol. 2000;95:156\u201362.","journal-title":"Clin Immunol"},{"key":"9834_CR24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1196\/annals.1405.042","volume":"1132","author":"BM Conti-Fine","year":"2008","unstructured":"Conti-Fine BM, Milani M, Wang W. CD4+ T cells and cytokines in the pathogenesis of acquired myasthenia gravis. Ann N Y Acad Sci. 2008;1132:193\u2013209.","journal-title":"Ann N Y Acad Sci"},{"key":"9834_CR25","doi-asserted-by":"crossref","first-page":"e826","DOI":"10.1111\/j.1365-2567.2009.03089.x","volume":"128","author":"L Mu","year":"2009","unstructured":"Mu L, Sun B, Kong Q, Wang J, Wang G, Zhang S, et al. Disequilibrium of T helper type 1, 2 and 17 cells and regulatory T cells during the development of experimental autoimmune myasthenia gravis. Immunology. 2009;128:e826\u201336.","journal-title":"Immunology"},{"key":"9834_CR26","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.clim.2009.03.523","volume":"132","author":"S Shandley","year":"2009","unstructured":"Shandley S, Martinez S, Krolick K. IL-4 receptor as a bridge between the immune system and muscle in experimental myasthenia gravis I: up-regulation of muscle IL-15 by IL-4. Clin Immunol. 2009;132:246\u201356.","journal-title":"Clin Immunol"},{"key":"9834_CR27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.fct.2011.10.043","volume":"50","author":"AQ Khan","year":"2012","unstructured":"Khan AQ, Khan R, Qamar W, Lateef A, Ali F, Tahir M, et al. Caffeic acid attenuates 12-O-tetradecanoyl-phorbol-13-acetate (TPA)-induced NF-kappaB and COX-2 expression in mouse skin: abrogation of oxidative stress, inflammatory responses and proinflammatory cytokine production. Food Chem Toxicol. 2012;50:175\u201383.","journal-title":"Food Chem Toxicol"},{"key":"9834_CR28","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2567.2006.02398.x","volume":"118","author":"BV Aruna","year":"2006","unstructured":"Aruna BV, Ben-David H, Sela M, Mozes E. A dual altered peptide ligand down-regulates myasthenogenic T cell responses and reverses experimental autoimmune myasthenia gravis via up-regulation of Fas-FasL-mediated apoptosis. Immunology. 2006;118:413\u201324.","journal-title":"Immunology"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-012-9834-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-012-9834-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-012-9834-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T04:14:53Z","timestamp":1559276093000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-012-9834-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,30]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["9834"],"URL":"https:\/\/doi.org\/10.1007\/s10875-012-9834-5","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,30]]}}}